WISE CVD - Continuation (WISE HFpEF)
Women's Ischemia Syndrome Evaluation (WISE) - Coronary Microvascular Dysfunction (CMD) and Heart Failure With Preserved Ejection Fraction (HFpEF)
Sponsor: Cedars-Sinai Medical Center
Listed as NCT02582021, this observational or N/A phase trial focuses on Cardiovascular Disease and Microvascular Coronary Dysfunction and remains actively recruiting participants. Sponsored by Cedars-Sinai Medical Center, it has been updated 18 times since 2015, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
18 versions recorded-
Aug 2025 — Present [monthly]
Recruiting
-
Oct 2024 — Aug 2025 [monthly]
Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Aug 2023 — Jul 2024 [monthly]
Recruiting
▶ Show 13 earlier versions
-
Dec 2021 — Aug 2023 [monthly]
Recruiting
-
Sep 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Jun 2019 — Nov 2020 [monthly]
Recruiting
-
Jan 2019 — Jun 2019 [monthly]
Recruiting
-
Jul 2018 — Jan 2019 [monthly]
Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Recruiting
-
May 2018 — Jun 2018 [monthly]
Recruiting
-
Apr 2018 — May 2018 [monthly]
Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Recruiting NA
-
Jul 2017 — Aug 2017 [monthly]
Recruiting NA
-
Jan 2017 — Jul 2017 [monthly]
Recruiting NA
First recorded
Nov 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cedars-Sinai Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .